Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Skip to main content

Contracts Grants Pricing Blog Glossary

Loading...

Kontrakk

The only workspace built for the work of government contracting.

Platform

Discovery feed
Pursuit board
Grants

Industries

Federal contractors
Defense primes
Nonprofit grants
Higher education

Resources

Help center
Developer docs

Company

About
Privacy
Terms of Service

© 2026 Kontrakk. All rights reserved.Government Contracts. Won with Confidence.

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Home
Grants
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

posted

synopsis

#PAR-25-210

Agency

National Institutes of Health

Code: HHS-NIH11

Description

No description available

Important Dates

Open Date

Oct 31, 2024

Close Date

Jun 2, 2027

CFDA Numbers

93.866

93.313

93.393

93.213

93.121

View on Grants.gov

More grants from National Institutes of Health

Single Source: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes: Data Resource and Administrative Coordination Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth)
National Institutes of Health
Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
Emerging Global Leader Award (K43)
National Institutes of Health
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
National Institutes of Health